Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?
Is CMPS a good stock to buy? We came across a bullish thesis on COMPASS Pathways plc on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on CMPS.
Compass Pathways Plc (CMPS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 12,161,496 | $67,253,073 | +66% | 1.1% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 4,038,335 | $22,331,992 | 0.02% | |
| 3. | Tang Capital Management Kevin C. Tang | 4,002,200 | $22,132,166 | 1.12% | |
| 4. | BIT Capital GmbH Jan Beckers | 3,491,234 | $19,306,524 | +1109% | 0.93% |
| 5. | ARK Investment Management Catherine D. Wood | 3,301,050 | $18,254,806 | +54% | 0.14% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 776,565 | $0.00 | 3,155,122 | 2024-10-24 | Filing | |
| $0.00 | 776,565 | $0.00 | 3,152,848 | 2024-10-24 | Filing | |
| $0.00 | 776,565 | $0.00 | 3,152,848 | 2024-10-24 | Filing | |
| $0.00 | 776,565 | $0.00 | 3,155,122 | 2024-10-24 | Filing | |
| $6.05 | 2,660,000 | $16,093,000.00 | 6,905,774 | 2024-09-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,632,390 | $58,797,117 | 0.59% | |
| 2. | 2,060,427 | $11,394,161 | 1.99% | |
| 3. | 2,021,407 | $11,178,381 | 5.19% | |
| 4. | 2,000,100 | $11,060,553 | 0.06% | |
| 5. | 1,855,070 | $10,258,537 | 0% |
News See All
COMPASS Pathways plc (NASDAQ:CMPS) Q1 2026 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways First Quarter Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
7 Small Cap Stocks with the Highest Upside Potential
On April 24, Peter Boockvar, One Point BFG Wealth Partners CIO, joined CNBC's 'Fast Money' to talk about why he believes that the market is becoming too nonchalant.
9 Best Psychedelic Stocks to Buy in 2026
The AdvisorShares Psychedelics ETF, a fund that primarily invests in the psychedelic drugs sector, is up 31% over the past year. That almost doubles the S&P 500’s 16% gain over the same timeframe.
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
TheFly reported on February 14 that LifeSci Capital was bullish on CMPS, as the firm initiated coverage on the stock with a Buy rating and a $15 price target.
7 Most Promising Psychedelic Stocks According to Hedge Funds
The psychedelic industry is poised to have a significant "second wave," transforming from a speculative, counterculture-driven movement into a recognized cornerstone of the US healthcare system.
Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution
COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now.
13 Best Get Rich Fast Stocks to Buy Right Now
In today's fast-paced world, everyone is prioritising investments that have both high and relatively quick returns.
COMPASS Pathways plc (NASDAQ:CMPS) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today.
COMPASS Pathways Plc (CMPS)’ Psilocybin Therapy Hits Phase 3 Success in Depression
COMPASS Pathways Plc (NASDAQ:CMPS), a biotechnology company specializing in innovative mental health treatments, is developing COMP360, a psilocybin-based therapy in late-stage development for treatment...